Related Experiment Video
Updated: Nov 12, 2025
04:02
Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024
1.4K
A Systematic Literature Review on Traumatic Optic Neuropathy
Saeed Karimi1,2, Amir Arabi1,2, Iman Ansari1,2
1Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Journal of Ophthalmology
|March 17, 2021
Summary
Traumatic optic neuropathy (TON) is a rare but serious vision disorder. Intravenous erythropoietin shows promise as a safe and effective treatment for TON, offering a potential new therapeutic option.
Area of Science:
- Ophthalmology
- Neurology
Background:
- Traumatic optic neuropathy (TON) is an uncommon, vision-threatening condition resulting from ocular or head trauma.
- It is classified into direct and indirect forms, with indirect TON being more prevalent.
Purpose of the Study:
- To review the mechanisms, diagnosis, and controversial management strategies for traumatic optic neuropathy.
- To evaluate the efficacy and safety of intravenous erythropoietin as a potential treatment for TON.
Main Methods:
- Literature review of traumatic optic neuropathy.
- Analysis of diagnostic indicators such as afferent pupillary defect.
- Evaluation of treatment outcomes for corticosteroids, optic nerve decompression, and erythropoietin.
Main Results:
- Diagnosis can be challenging, especially with pupillary constriction from narcotics or bilateral TON.
- High-dose corticosteroids and optic nerve decompression have not shown benefits over observation.
- Intravenous erythropoietin demonstrated potential as a safe and efficient treatment for TON.
Conclusions:
- The management of TON remains debated, with observation being a standard approach.
- Intravenous erythropoietin presents a promising therapeutic avenue for patients with traumatic optic neuropathy.
Related Concept Videos
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:27Open Angle Glaucoma: Treatment
811
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
811
01:28Angle Closure Glaucoma: Treatment
938
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
938